Analysis of microbiota in stable patients with chronic obstructive pulmonary disease

APMIS

Volumn 123, Issue 5, 2015, Pages 427-432

  Aguirre, Estefania ^a   Galiana, Antonio ^a   Mira, Alejandro ^b   Guardiola, Ramón ^c   Sánchez Guillén, Laura ^a   Garcia Pachon, Eduardo ^a   Santibañez, Miguel ^d   Royo, Gloria ^a,e   Rodríguez, Juan Carlos ^c,e  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

COPD; Sputum microbiota

Indexed keywords

ACTINOMYCES; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; ENTEROBACTERIACEAE; FEMALE; FORCED EXPIRATORY VOLUME; FUSOBACTERIUM; GEMELLA; GENETIC PROCEDURES; GRANULICATELLA; HAEMOPHILUS; HUMAN; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROFLORA; MORAXELLA; NEISSERIA; PATHOGENESIS; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; PYROSEQUENCING; ROTHIA; SPUTUM; SPUTUM CULTURE; STREPTOCOCCUS; VEILLONELLA; BACTERIUM; BACTERIUM IDENTIFICATION; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; METAGENOME; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PROCEDURES; PROSPECTIVE STUDY; VERY ELDERLY;

BACTERIAL DNA; BACTERIAL RNA; RNA 16S;

AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL TYPING TECHNIQUES; DNA, BACTERIAL; FEMALE; HUMANS; MALE; METAGENOME; MICROBIOTA; MIDDLE AGED; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SPUTUM;

EID: 84928290254     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12363     Document Type: Article

References (26)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011 Management and Prevention of COPD. Available at: http://www.goldcopd.org/.
2. Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64:863-8.
3. Matkovic Z, Miravitlles M. Chronic bronchial infection in COPD. Is there an infective phenotype? Respir Med 2013;107:10-22.
4. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
5. Angrill J, De Agusti C, Celis R, Raño A, Gonzalez J, Sole T, et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002;57:15-9.
6. Sykes A, Mallia P, Johnston SL. Diagnosis of pathogens in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4:642-6.
7. Wilkinson TMA, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1090-5.
8. Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-64.
9. Petrosino JF, Highlander S, Luna RA, Gibbs RA, Versalovic J. Metagenomic pyrosequencing and microbial identification. Clin Chem 2009;55:856-66.
10. Rogers GB, Bruce KD. Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application. Mol Diagn Ther 2010;14:343-50.
11. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011;127:372-81.
12. Bittar F, Richet H, Dubus JC, Reynaud-Gaubert M, Streimer N, Sarles J, et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS ONE 2008;3:e2908.
13. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185:1073-80.
14. Erb-Downward JR, Huffnagle G, Martinez FJ. The Microbiota in Respiratory Disease. Am J Respir Crit Care Med 2012;185:1037-8.
15. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010;5:e8578.
16. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 2010;14:9-17.
17. Erb-Downward JR, Thomson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, et al. Analysis of the lung microbiome in the 'healthy' smoker and in COPD. PLoS ONE 2011;6:2.
18. Williamson SJ, Yooseph S. From bacterial to microbial ecosystems (metagenomics). Methods Mol Biol 2012;804:35-55.
19. Han MK, Huang YJ, Lipuma JJ, Boushey HA, Boucher RC, Cookson WO, et al. Significance of the microbiome in obstructive lung disease. Thorax 2012;67:456-63.
20. Bailey MT, Dowd SE, Parry NM, Galley JD, Schauer DB, Lyte M. Stressor exposure disrupts commensally microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun 2010;78:1509-19.
21. Sialer S, Adamantia L, Guerrero M, Torres A. Relation between chronic obstructive pulmonary disease and antibiotics. Curr Infect Dis Resp 2012;14:300-7.
22. Frank DN, StAmand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007;104:13780-5.
23. Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagaña X, Gayete A, et al. PAC-COPD Study Group. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011;66:430-7.
24. Cabrera-Rubio R, Garcia-Núñez M, Setó L, Antó JM, Moya A, Monsó E, et al. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J Clin Microbiol 2012;50:3562-8.
25. Soriano JB, Brusasco V, Dinh-Xuan AT. The European Respiratory Journal makes COPD a priority. Eur Respir J 2011;38:999-1001.
26. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-14.